News & Events

  • April 16, 2013

    Oxigene Inc. announced the closing of their PIPE offering in the amount of $5,000,000. EG&S acted as counsel to the Placement Agent.

  • April 09, 2013

    Cardium Therapeutics, Inc. announced the closing of their Registered Direct offering in the amount of $2,356,000.  EG&S acted as counsel to the Investor.

  • March 27, 2013

    Vuzix Corporation announced the closing of their PIPE offering in the amount of $800,000. EG&S acted as counsel to the Investor.

  • March 27, 2013

    Douglas S. Ellenoff, a member of the Firm, was invited by NowStreet to participate in Part I of their webinar series, “Capitalizing on Financial Innovation."  The webinar focused on crowdfunding and aimed at properly preparing investors, asset allocators and issuers for the forthcoming Crowdfunding Revolution.

  • March 27, 2013

    Douglas S. Ellenoff, a member of the Firm, was invited by Merrill DataSite to participate in their webinar "JOBS Act: Leveling the Playing Field for Small/Micro-Cap Companies in the Capital Markets."  Topics addressed included: how the JOBS Act redefined the playing field for small and micro-cap companies; which industries and regions present the best opportunities for investment in the small/micro-cap space; what are the financing and venture opportunities currently for start-ups and how has crowd-funding changed the game; what impact will the JOBS Act have on the IPO market in 2013, and what impact will the JOBS Act have on larger companies in the long-term.

  • March 27, 2013

    Krinos Foods LLC closed a $6,000,000 revolving loan with Provident Bank.  EG&S acted as counsel to Krinos.

  • March 20, 2013

    CombiMatrix Corp. announced the closing of their Registered Direct offering in the amount of $2,006,900. EG&S acted as counsel to the Investor.

  • March 15, 2013

    ARI Network Services, Inc. announced the closing of their PIPE offering in the amount of $4,800,000. EG&S acted as counsel to the Investor.

  • March 14, 2013

    Park City Group, Inc. announced the closing of their PIPE offering in the amount of $1,100,001. EG&S acted as counsel to the Placement Agent.

  • March 13, 2013

    Wave Systems Corp. announced the closing of their PIPE offering in the amount of $1,000,000. EG&S acted as counsel to the Placement Agent.

  • March 07, 2013

    EntreMed, Inc. announced the closing of their Registered Direct offering in the amount of $11,000,000.  EG&S acted as counsel to the Placement Agent.

  • March 05, 2013

    Tribute Pharmaceuticals Canada Inc. announced the closing of their PIPE offering in the amount of $895,000.  EG&S acted as counsel to the Placement Agent.

  • February 27, 2013

    Oxygen Biotherapeutics Inc. announced the closing of their PIPE and Registered Direct offering in the amount of $2,100,000.  EG&S acted as counsel to the Placement Agent.

  • February 27, 2013

    Tribute Pharmaceuticals Canada Inc. announced the closing of their PIPE offering in the amount of $3,375,000.  EG&S acted as counsel to the Placement Agent.

  • February 26, 2013

    Celsion Corporation announced the closing of their Registered Direct offering in the amount of $15,000,004.  EG&S acted as counsel to the Placement Agent.

  • February 22, 2013

    Provectus Pharmaceuticals, Inc. announced the closing of their PIPE offering in the amount of $2,550,000. EG&S acted as counsel to the Investor.

  • February 20, 2013

    Novelos Therapeutics, Inc. announced the closing of their PIPE offering in the amount of $5,500,000.  EG&S acted as counsel to the Placement Agent.

  • February 15, 2013

    Atlas Financial Holdings, Inc. announced the closing of its initial public offering; 1,500,000 shares were sold by AFH and 2,625,000 shares were sold on behalf of selling shareholders. Total proceeds raised in the offering were $23,517,000. EG&S acted as counsel to Atlas.

  • February 15, 2013

    Nautilus Marine Acquisition Corp. (NASDAQ:NMAR) announced the completion of its acquisition of Assetplus Limited, a maritime energy services company controlling an initial fleet of vessels consisting of two platform supply vessels and two oil spill response vessels, as well as six binding time charter contracts with Brazilian oil major Petróleo Brasileiro S.A.  In connection therewith, Nautilus completed its self-tender offer for up to 4,137,300 shares of its common stock at a price of $10.10 per share. EG&S acted as counsel to Nautilus.

  • February 14, 2013

    Desert Gateway, Inc. announced the closing of their PIPE offering in the amount of $10,000,000. EG&S acted as counsel to the Investor.

  • February 11, 2013

    Opexa Therapeutics, Inc. announced the closing of their Registered Direct offering in the amount of $3,250,002.  EG&S acted as counsel to the Placement Agent.
     

  • February 05, 2013

    ARCA biopharma, Inc. announced the closing of their Registered Direct offering in the amount of $729,998.  EG&S acted as counsel to the Placement Agent.

  • January 31, 2013

    Morria Biopharmaceuticals PLC announced the closing of their Registered Direct offering in the amount of $10,000,000.  EG&S acted as counsel to the Placement Agent.
     

  • January 30, 2013

    Arrowhead Research Corp. announced the closing of their Confidentially Marketed Public offering in the amount of $1,250,002.  EG&S acted as counsel to the Placement Agent.

  • January 29, 2013

    Douglas S. Ellenoff, a member of the Firm, was invited by the Inter American Development Bank and Multilateral Investment Fund to participate in their workshop “Crowdfunding: Financing Ideas, Entrepreneurs and Institutions The Market in Latin America and the Caribbean.” Mr. Ellenoff was part of two different panels: Discussion of Regulatory Aspects and Business Models Emerging due to the JOBS Act and Crowdfunding with Financial Returns.